These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 9119032)
1. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten. Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032 [TBL] [Abstract][Full Text] [Related]
2. Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity. Tawfik DS; Zemel RR; Arad-Yellin R; Green BS; Eshhar Z Biochemistry; 1990 Oct; 29(42):9916-21. PubMed ID: 2271630 [TBL] [Abstract][Full Text] [Related]
3. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis. Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500 [TBL] [Abstract][Full Text] [Related]
4. Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving-group determinant: evidence for the 'flexibility' hypothesis. Gul S; Sonkaria S; Pinitglang S; Florez-Alvarez J; Hussain S; Thomas EW; Ostler EL; Gallacher G; Resmini M; Brocklehurst K Biochem J; 2003 Dec; 376(Pt 3):813-21. PubMed ID: 12946271 [TBL] [Abstract][Full Text] [Related]
5. A comparison of flexible and constrained haptens in eliciting antibody catalysts for paraoxon hydrolysis. Spivak DA; Hoffman TZ; Moore AH; Taylor MJ; Janda KD Bioorg Med Chem; 1999 Jun; 7(6):1145-50. PubMed ID: 10428386 [TBL] [Abstract][Full Text] [Related]
6. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog. Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011 [TBL] [Abstract][Full Text] [Related]
8. Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody. Gigant B; Charbonnier JB; Eshhar Z; Green BS; Knossow M J Mol Biol; 1998 Dec; 284(3):741-50. PubMed ID: 9826512 [TBL] [Abstract][Full Text] [Related]
9. Evolution of catalytic antibody repertoire in autoimmune mice. Nishi Y J Immunol Methods; 2002 Nov; 269(1-2):213-33. PubMed ID: 12379363 [TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies. Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836 [TBL] [Abstract][Full Text] [Related]
11. Peptide synthesis catalyzed by an antibody containing a binding site for variable amino acids. Hirschmann R; Smith AB; Taylor CM; Benkovic PA; Taylor SD; Yager KM; Sprengeler PA; Benkovic SJ Science; 1994 Jul; 265(5169):234-7. PubMed ID: 8023141 [TBL] [Abstract][Full Text] [Related]
12. Multiple reactive immunization towards the hydrolysis of organophosphorus nerve agents: hapten design and synthesis. Huang H; Han WG; Noodleman L; Grynszpan F Bioorg Med Chem; 2001 Dec; 9(12):3185-95. PubMed ID: 11711294 [TBL] [Abstract][Full Text] [Related]
13. Enantioselective hydrolysis of naproxen ethyl ester catalyzed by monoclonal antibodies. Shi ZD; Yang BH; Zhao JJ; Wu YL; Ji YY; Yeh M Bioorg Med Chem; 2002 Jul; 10(7):2171-5. PubMed ID: 11983513 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of the broad substrate tolerance of the antibody 7B9-catalyzed hydrolysis of p-nitrobenzyl esters. Miyamoto N; Yoshimura M; Okubo Y; Suzuki-Nagata K; Tsumuraya T; Ito N; Fujii I Bioorg Med Chem; 2018 May; 26(8):1412-1417. PubMed ID: 29496413 [TBL] [Abstract][Full Text] [Related]
15. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens. Odenbaugh AL; Helms ED; Iverson BL Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164 [TBL] [Abstract][Full Text] [Related]
16. Cocaine catalytic antibodies: the primary importance of linker effects. Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477 [TBL] [Abstract][Full Text] [Related]
17. Hapten design for the generation of catalytic antibodies. Thomas NR Appl Biochem Biotechnol; 1994; 47(2-3):345-72. PubMed ID: 7944348 [TBL] [Abstract][Full Text] [Related]
18. Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure. Cashman JR; Berkman CE; Underiner GE J Pharmacol Exp Ther; 2000 Jun; 293(3):952-61. PubMed ID: 10869397 [TBL] [Abstract][Full Text] [Related]
19. Detection of catalytic monoclonal antibodies. Tawfik DS; Green BS; Eshhar Z Anal Biochem; 1992 Apr; 202(1):35-9. PubMed ID: 1621985 [TBL] [Abstract][Full Text] [Related]
20. Similarities of hydrolytic antibodies revealed by their X-ray structures: a review. Charbonnier JB; Gigant B; Golinelli-Pimpaneau B; Knossow M Biochimie; 1997 Nov; 79(11):653-60. PubMed ID: 9479447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]